Immunome Inc 10-K for FY2024
Immunome Inc. (IMNM)
10-K
2025-03-19
For: 2024-12-31
View Original
Added on
April 12, 2026
About this 10-K
Immunome Inc filed this 10-K on March 19, 2025, covering the fiscal year ended December 31, 2024 (FY2024).
Headline figures
Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $9.04M
- down 35.5% from $14.02M a year earlier
- Net loss
- $292.96M
- compared with a net loss of $106.81M a year earlier
- Diluted EPS
- -$5.00
- compared with -$5.38 a year earlier